Debut (Debut Biotech) is a verified, high-growth synthetic biology company backed by significant venture capital (~$126M Series B) and strategic partners like L'Oreal. The project claims 'TIME100 Most Innovative Companies 2025' status, which is supported by search results indicating high industry recognition. However, the specific submission quality is extremely poor: the user ('ThunderShade') provided vague, hyperbolic claims ('most people have used my product') and confusing financial data ('marketcap: 2500000', likely an error for $2.5B valuation or monthly revenue, as actual funding is much higher). Despite the low-effort submission, the underlying technology (cell-free biomanufacturing) and market position are exceptionally strong, warranting a high score adjusted for the lack of provided detail.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline